On September, 12, AmCham Healthcare Committee will meet with the Medicines and Medical Devices Agency to discuss the newly approved regulation on pharmacovigilance activity, impacting holders of marketing authorizations for drugs, as well as patients, and healthcare professionals.
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
---|---|---|---|---|---|---|
Latest Advocacy on the Go